HeartFlow, Inc.
26
7
8
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
11.5%
3 terminated/withdrawn out of 26 trials
78.6%
-8.0% vs industry average
8%
2 trials in Phase 3/4
73%
8 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (26)
REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care
Role: lead
REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease
Role: lead
AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management
Role: lead
Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention
Role: collaborator
Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department
Role: lead
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
Role: collaborator
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
Role: lead
The COMPLETE Study
Role: collaborator
Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease
Role: collaborator
The PLATFORM Study: Prospective LongitudinAl Trial of FFRct: Outcome and Resource IMpacts)
Role: lead
Using CTA Measures to Define Cardiac Risk In NFL Alumni
Role: lead
The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA
Role: lead
Assessing Diagnostic Value of Non-invasive FFRCT in Coronary Care
Role: lead
CMR Versus CT in Coronary Artery Disease
Role: collaborator
Influence of Lipid Lowering on Impaired Coronary Flow
Role: collaborator
DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR
Role: collaborator
The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization
Role: lead
The Value of CT Fractional Flow Reserve
Role: collaborator
Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG)
Role: collaborator
Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography
Role: lead